Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Breaking & Recent News Twist Bioscience Corporation TWST

Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throu...


Recent & Breaking News (NDAQ:TWST)

Twist Bioscience Enhances DNA Storage Capabilities Through Agreement With Imagene SA

Business Wire July 25, 2019

Twist Bioscience to Report Fiscal 2019 Third Quarter Financial Results on Thursday, August 1, 2019

Business Wire July 25, 2019

Twist Bioscience Launches Mouse Exome to Power Genetic Research

Business Wire June 17, 2019

Twist Bioscience to Present at the Jefferies 2019 Global Healthcare Conference

Business Wire May 28, 2019

Twist Bioscience Strengthens Board With Semiconductor and Storage Expert Nelson C. Chan

Business Wire May 23, 2019

Collaboration of Four Biotech Companies Showcases High Throughput DNA Assembly Platform for Diverse Applications

Business Wire May 23, 2019

Twist Bioscience Announces Closing of Upsized Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares

Business Wire May 13, 2019

Twist Bioscience Announces Pricing of $78.8 Million Public Offering of Common Stock

Business Wire May 8, 2019

Twist Bioscience Announces Proposed Public Offering of Common Stock

Business Wire May 6, 2019

Twist Bioscience Reports Second Quarter Fiscal 2019 Financial Results and Highlights Commercial and Operational Progress

Business Wire April 30, 2019

Twist Bioscience Announces Synthetic DNA Biosecurity Publication in Frontiers

Business Wire April 25, 2019

Twist Bioscience to Report Fiscal 2019 Second Quarter Financial Results on Tuesday, April 30, 2019

Business Wire April 18, 2019

Twist Bioscience and iGEM Partner to Provide Synthetic DNA for iGEM Competition and Registry

Business Wire April 15, 2019